Metraipolis › archive › dc_fc1bc2d4b7cb

Impact of carboplatin schedule on pCR in a modified KEYNOTE-522 regimen with dose-dense AC for triple negative breast cancer — Europe PMC PMID:41259056

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41259056
DOI
10.1093/oncolo/oyaf372
License (as archived)
solo-consultazione
Archived
2026-11-08T20:58:45.326Z
SHA-256 of the archived text
c8007fe07caf11ce8e0de0feead4d08369b517ed57c3c0241d92b7189d3476da
Stable URL of this page
https://metraipolis.com/documento/dc_fc1bc2d4b7cb

How to cite

Impact of carboplatin schedule on pCR in a modified KEYNOTE-522 regimen with dose-dense AC for triple negative breast cancer — Europe PMC PMID:41259056 — Europe PMC (en), https://europepmc.org/article/MED/41259056 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc1bc2d4b7cb (Metraipolis archive dc_fc1bc2d4b7cb, sha256 c8007fe07caf11ce8e0de0feead4d08369b517ed57c3c0241d92b7189d3476da)
BibTeX
@misc{dcfc1bc2d4b7cb,
  title = {Impact of carboplatin schedule on pCR in a modified KEYNOTE-522 regimen with dose-dense AC for triple negative breast cancer — Europe PMC PMID:41259056},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41259056},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc1bc2d4b7cb; sha256 c8007fe07caf11ce8e0de0feead4d08369b517ed57c3c0241d92b7189d3476da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41259056. Agents can read the archived copy with the MCP tool read_document.